Influenza

Influenza (the flu) is a contagious respiratory illness caused by influenza viruses. It can cause mild to severe illness, and at times can lead to death. The best way to prevent the flu is by getting a flu vaccination each year. Every year in the United States, on average 5% to 20% of the population gets the flu; more than 200,000 people are hospitalized from flu complications, and; about 36,000 people die from flu-related causes. Some people, such as older people, young children, and people with certain health conditions, are at high risk for serious flu complications.
Types of Influenza

Influenza is caused by three types of RNA viruses called influenza types A, B and C, which all belong to the family Orthomyxoviridae.

Read More

Overview

Feature Articles

Latest Influenza News and Research

Claims that CDC’S PCR test can’t tell covid from flu are wrong

Claims that CDC’S PCR test can’t tell covid from flu are wrong

Scientists suspect Lambda SARS-CoV-2 variant most dangerous

Scientists suspect Lambda SARS-CoV-2 variant most dangerous

SARS-CoV-2 interacts with sialic acid cell surface glycans

SARS-CoV-2 interacts with sialic acid cell surface glycans

Streptococcus pneumoniae modulates host immunity to SARS-CoV-2

Streptococcus pneumoniae modulates host immunity to SARS-CoV-2

Study reveals cellular basis of antigen-specific response to Pfizer-BioNTech’s COVID-19 vaccine

Study reveals cellular basis of antigen-specific response to Pfizer-BioNTech’s COVID-19 vaccine

NIH scientists demonstrate efficient aerosol transmission of SARS-CoV-2 in hamsters

NIH scientists demonstrate efficient aerosol transmission of SARS-CoV-2 in hamsters

Study suggests mRNA SARS-CoV-2 vaccines remain effective against variants

Study suggests mRNA SARS-CoV-2 vaccines remain effective against variants

CDC study on efficacy of mRNA vaccines against symptomatic COVID-19

CDC study on efficacy of mRNA vaccines against symptomatic COVID-19

Rosin soap as a potential SARS-CoV-2 disinfectant

Rosin soap as a potential SARS-CoV-2 disinfectant

CoVizu: Making visual sense of variation in SARS-CoV-2 genomes

CoVizu: Making visual sense of variation in SARS-CoV-2 genomes

Advantages and challenges of intranasal vaccines to fight against COVID-19 infections

Advantages and challenges of intranasal vaccines to fight against COVID-19 infections

Clinical trials during a pandemic – lessons from COVID-19

Clinical trials during a pandemic – lessons from COVID-19

SARS-CoV-2 genomic surveillance identifies intricacies of stabilizing vs. destabilizing mutations

SARS-CoV-2 genomic surveillance identifies intricacies of stabilizing vs. destabilizing mutations

Human coronaviruses need organic materials to transfer efficiently between surfaces

Human coronaviruses need organic materials to transfer efficiently between surfaces

Scientists explore susceptibility of different animals to SARS-CoV-2 infection

Scientists explore susceptibility of different animals to SARS-CoV-2 infection

Reusable N95 masks could offer reduction in waste and cost, study shows

Reusable N95 masks could offer reduction in waste and cost, study shows

CEPI and IVI announce new research program to expand access to COVID-19 vaccines in Africa

CEPI and IVI announce new research program to expand access to COVID-19 vaccines in Africa

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Patient's case report reveals link between Bell’s palsy and Pfizer-BioNTech vaccine

Patient's case report reveals link between Bell’s palsy and Pfizer-BioNTech vaccine

Plant-based vaccines for COVID-19 and other viruses

Plant-based vaccines for COVID-19 and other viruses